Skip to content
Focus Pro Magazine

Social Media Content Creators Driving Unofficial Trade for Unlicensed Weight-Loss Drug

An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these profiles directly for source information, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a robust market exists on messaging services, where communities with numerous of participants share comparison images, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could result in users injecting substances of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Material Removal

According to TikTok, the platform has taken down violative content and prohibited related keywords and query recommendations. The organization stated it was committed to keeping the platform safe and investing in strengthening compliance measures.

Digital Marketplace Operations

Research also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, populated with images of slimming results, positive testimonials and detailed guides for mixing or injecting at residence.

Within moments of entering one group, a vendor posted contact information, where most transactions take place. The seller sent an guidebook and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.

Item Information and Costs

Within these groups, messages show black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already encountered individuals harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject users to possibly serious health risks”.

About the author

Mark Bowman

Elena Vance is a seasoned business analyst and tech writer with over a decade of experience covering emerging market trends and digital transformation strategies.

Focus Pro Magazine

Type to search articles.